THE CODI Co.,LTD. (KOSDAQ:224060)

Market Cap	24.46B +14.5%
Revenue (ttm)	33.17B +9.6%
Net Income	-5.40B
EPS	-1,065.89
Shares Out	5.13M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	130,214
Average Volume	134,639
Open	5,500.00
Previous Close	5,650.00
Day's Range	4,710.00 - 5,500.00
52-Week Range	2,400.00 - 6,590.00
Beta	0.55
RSI	56.26
Earnings Date	Mar 20, 2026

About THE CODI Co.,LTD.

THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. THE CODI Co.,LTD. was formerly known as CODI-M Co., LTD. and changed its name to THE CODI Co.,LTD. in November 2022. THE CODI Co.,LTD. was incorporated in 1999 and is based in Cheonan-si, South Korea.

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1999
• Employees: 39
• Stock Exchange: KOSDAQ
• Ticker Symbol: 224060

Financial Performance

In 2024, THE CODI Co.,LTD.'s revenue was 33.52 billion, an increase of 65.82% compared to the previous year's 20.21 billion. Losses were -3.48 billion, -56.34% less than in 2023.